The 20 Best Cone-Rod Dystrophy Doctors near Teaneck, NJ

"Stephen H. Tsang, M.D, Ph.D. is an acclaimed clinical geneticist in the care of individuals with retinal degenerations. He has been culturing stem cells since 1992 and created the first mouse model for a recessive form of retinitis pigmentosa (RP) by applying genome engineering to stem cell technology in 1995. He successfully treated preclinical models of Pde6a, Pde6b, Mfrp, Rho, Cngb1 and autosomal recessive bestrophin retinopathies.He has expertise in designing and testing genome engineering strategies in pre-clinical models, developing patient-specific knock-in models, generating of patient cell lines and providing care to patients with a precision medicine approach. He is also leading efforts in FDA trials for gene therapies, including PDE6A, RAB geranylgeranyl transferase, RPGR, CNGB3, CNGA3 and ABCA4 retinopathies. He wrote 3 books: “Precision Medicine, CRISPR, and Genome Engineering: Moving from Association to Biology and Therapeutics"" and “Stem Cell Biology and Regenerative Medicine in Ophthalmology”, Springer Press, NY; and “CRISPR Genome Surgery in Stem Cells and Disease Tissues”, Elsevier Inc. He is an elected member of several honorary societies including the American Society for Clinical Investigation, Alcon Research Institute and American Ophthalmological Society. He is consistently named to various NIH study sections (DPVS standing member 2014-8 and PED2 2022-6) and other review committees; Alcon Research Institute Grant Review Committee (2022-27), Scientific Advisory Panel - Research to Prevent Blindness (RPB, 2019-29), Chair of American Ophthalmological Society Thesis Review Committee (2022-2023). Many of his publications are in widely-read general interest journals such as Science, NEJM, Lancet, Cell Stem Cell, Nature Genetics, and Journal of Clinical Investigation, which attests to the broad impact that his work has had.Dr. Tsang received a resident teaching award in 2008 and was the Columbia Ophthalmology Basic Science Course Director (2006-2018). Dr. Tsang graduated from Johns Hopkins University, where he began his medical genetics training under the tutelage of Professor Victor A. McKusick. He received his M.D. and Ph.D. degrees from the NIH-National Institute of General Medical Sciences Medical Scientist Training Program (MSTP) at Columbia University. Dr. Tsang then completed his residency at Jules Stein Eye Institute/UCLA, followed by studies with Professors Alan C. Bird and Graham E. Holder on improving the care of individuals with macular degenerations.". Dr. Tsang is rated as a Distinguished provider by MediFind in the treatment of Cone-Rod Dystrophy. His top areas of expertise are Retinopathy Pigmentary Mental Retardation, Sorsby Fundus Dystrophy, Leber Congenital Amaurosis, and Usher Syndrome.

Scott E. Brodie, MD, Ph.D., is a Professor of Clinical Ophthalmology and Attending Ophthalmologist in the Department of Ophthalmology. He is an internationally known clinician-scientist, and a leader in the use of electrophysiologic techniques for diagnosing of visual impairments in children and adults.Dr. Brodie is a graduate of the combined MD-PhD program at Weill-Cornell Medical College and The Rockefeller University in New York. He completed his PhD in retinal physiology in the laboratory of Nobel Laureate H. K. Hartline, under the supervision of Dr. Floyd Ratliff and Prof. Bruce Knight. He completed a medical internship and residency training in ophthalmology at The New York Hospital, and subsequently received fellowship training in medical retinal disorders and clinical electrophysiology of vision at New York University and Bellevue Hospital under the supervision of Dr. Ronald Carr, with support as a John Kluge Fellow of the Retinitis Pigmentosa Foundation.He is a fellow of the American Academy of Ophthalmology, and a fellow of the Association for Research in Vision and Ophthalmology. He is a member of the International Society for Clinical Electrophysiology of Vision, the International Society for Genetic Eye Disease, and the Ophthalmic Genetics Study Club. Dr. Brodie has been honored with the Senior Achievement Award of the American Academy of Ophthalmology, as well as the Academy's Secretariat Award for Education.Dr. Brodie’s research centers on improving methodologies for electrophysiologic testing, and descriptions of novel findings in patients with inherited and metabolic retinal disorders. He has been a key member of the teams which have introduced important new therapies, including enzyme-replacement therapy for Fabry disease, and intra-arterial chemotherapy for retinoblastoma, which has increased the rate of salvage of diseased eyes in the most severely affected patients from 20% to over 90%.Dr. Brodie has published extensively on electrophysiology and retinal disorders. He has a particular interest in clinical optics, and has served as Chair of the Editorial committee for the American Academy of Ophthalmology’s Basic and Clinical Science Course on Clinical Optics for the past ten years. In his spare time, he enjoys reading mathematics, and playing the oboe in local orchestras and chamber groups. Dr. Brodie is rated as a Distinguished provider by MediFind in the treatment of Cone-Rod Dystrophy. His top areas of expertise are Retinoblastoma, Retinitis Pigmentosa, Cone-Rod Dystrophy, Retinopathy Pigmentary Mental Retardation, and Vitrectomy.

Dr. Yannuzzi has made numerous innovative and lasting contributions in imaging, drug development, and therapeutic modalities. He was the first to use oral non-steroid anti-inflammatory medication for the treatment of cystoid macular edema and developed an eye drop to treat this condition. He has described new diseases as well as new associations and manifestations of established entities and photosensitization.He has published over 400 scientific papers and 13 books, which have earned him respect and admiration in the ophthalmic-retinal community and retina specialists internationally. He is well recognized as a devoted and excellent educator, a superb clinical diagnostician, and a prolific organizer of retinal meetings worldwide. Dr. Yannuzzi is rated as an Advanced provider by MediFind in the treatment of Cone-Rod Dystrophy. His top areas of expertise are Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Adult-Onset Vitelliform Macular Dystrophy (AVMD), and Vitrectomy.

Dr. Fisher is a clinical ophthalmologist specializing in vitreoretinal diseases. Dr. Fisher’s career is noteworthy in the areas of patient care, teaching, and research. He is the author of several textbooks in the field of vitreoretinal diseases and ultrasonography.AuthorDr. Fisher has published more than 50 scientific articles and numerous scientific exhibits and posters. He was a course director for the American Academy of Ophthalmology for over 22 years and a review editor for many prestigious ophthalmic journals. He has received numerous awards for national and international professorships and lectureships. He has also been awarded the coveted Senior Award from the American Academy of Ophthalmology.LecturesDr. Fisher has lectured throughout the United States and abroad in the areas of ultrasonography and vitreoretinal surgery, developing new techniques and instruments in his field as well as pioneering developments in ocular endoscopy. He was selected by departmental chairmen and section chiefs at major ophthalmology centers nationwide as one of the 400 best retina doctors in America.Developed InstrumentsDr. Fisher has developed numerous intraocular surgical instruments which have advanced the field of vitreoretinal surgery. These instruments include electromagnets as well as endoscopic techniques for situations where microscopic visualization is limited or impossible. Dr. Fisher is rated as an Experienced provider by MediFind in the treatment of Cone-Rod Dystrophy. His top areas of expertise are Late-Onset Retinal Degeneration, Adult-Onset Vitelliform Macular Dystrophy (AVMD), Age-Related Macular Degeneration (ARMD), Retinal Detachment, and Vitrectomy.

Luis Gonzalez is an Ophthalmologist in Teaneck, New Jersey. Dr. Gonzalez is rated as an Experienced provider by MediFind in the treatment of Cone-Rod Dystrophy. His top areas of expertise are Neuroretinitis, Uveitis, Retinal Detachment, and Diabetic Retinopathy.

Alyson Yashar is an Ophthalmologist in Hackensack, New Jersey. Dr. Yashar is rated as an Experienced provider by MediFind in the treatment of Cone-Rod Dystrophy. Her top areas of expertise are Meibomianitis, Hyperferritinemia-Cataract Syndrome, Eyelid Bump, and Strabismus.

Michael Rosenberg is an Ophthalmologist in Fort Lee, New Jersey. Dr. Rosenberg is rated as an Experienced provider by MediFind in the treatment of Cone-Rod Dystrophy. His top areas of expertise are Subconjunctival Hemorrhage, Cataract, Interstitial Keratitis, and Meibomianitis.

Elana Rosenberg is an Ophthalmologist in Rochelle Park, New Jersey. Dr. Rosenberg is rated as an Experienced provider by MediFind in the treatment of Cone-Rod Dystrophy. Her top areas of expertise are Glaucoma, Cataract, Kallikrein Hypertension, and Pigment-Dispersion Syndrome.

Ravi Radhakrishnan is an Ophthalmologist in Mount Vernon, New York. Dr. Radhakrishnan is rated as an Advanced provider by MediFind in the treatment of Cone-Rod Dystrophy. His top areas of expertise are Adult-Onset Vitelliform Macular Dystrophy (AVMD), Usher Syndrome, Doyne Honeycomb Retinal Dystrophy, and Usher Syndrome Type 2A.

Dr. Cooney is a practicing vitreoretinal surgeon who was previously an assistant professor of ophthalmology at Johns Hopkins University and later became the director of the Medical Retina Service, the Duke Center for Macular Degeneration, and the medical retina fellowship program from 2001 to 2005. He received a MBA degree from Kenan-Flagler Business School at the University of North Carolina, Chapel Hill.Dr. Cooney serves as a consultant and advisory board member for several pharmaceutical companies. In 1998, Dr. Cooney helped to establish InnoRx, an ophthalmic drug delivery and pharmaceutical company acquired by SurModics and served as a consultant from 2000 to 2002.Dr. Cooney’s clinical practice focuses on the medical and surgical treatment of vitreoretinal diseases, particularly age-related macular degeneration and diabetic retinopathy. He is actively involved in the clinical development of new diagnostic and therapeutic modalities for vitreoretinal disease and the training of residents and fellows.,Dr. Cooney helped establish InnoRx, an ophthalmic drug delivery and pharmaceutical company acquired by SurModics. Dr. Cooney is rated as an Advanced provider by MediFind in the treatment of Cone-Rod Dystrophy. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Doyne Honeycomb Retinal Dystrophy, and Cone Dystrophy.

Stuart Noorily is an Ophthalmologist in Teaneck, New Jersey. Dr. Noorily is rated as an Advanced provider by MediFind in the treatment of Cone-Rod Dystrophy. His top areas of expertise are Jalili Syndrome, Eales Disease, Uveitis, and Late-Onset Retinal Degeneration.

Dr. Jason Horowitz, Professor of Ophthalmology at Columbia University Irving Medical Center, joined Columbia in 2011 after a rewarding 25-year experience delivering retinal care to the Waterbury, Connecticut community. A graduate of Harvard College and Yale Medical School, Dr. Horowitz was an ophthalmology resident at Yale before completing a retinal fellowship at Cornell, where he trained under Dr. Stanley Chang.Dr. Horowitz’s interests in ophthalmology are wide ranging. He is currently Medical Director of the Residents’ Eye Clinic at Harkness, where some of the most complicated and diverse patients in the world are evaluated and treated for an astonishing variety of ocular diseases. In a completely different domain, Dr. Horowitz has assumed the role of performing essential evaluations for retinopathy of prematurity in the infant patients of the world famous neonatal intensive care unit at Columbia’s Morgan Stanley Children’s Hospital of New York.In yet another realm, Dr. Horowitz manages complex retinal and macular disorders in adults such as retinal detachments and macular pucker. Together with his 36 years of retinal practice experience, Dr. Horowitz employs the full range of cutting-edge medical and surgical modalities in his practice. He particularly values the ability to use the most improved, up-to-date laser, pharmacological, and surgical therapies to successfully prevent (and, in some cases, even correct) profound visual impairment in conditions such as diabetic retinopathy and macular holes or epiretinal membranes. Dr. Horowitz is rated as an Experienced provider by MediFind in the treatment of Cone-Rod Dystrophy. His top areas of expertise are Retinopathy of Prematurity, Retinal Detachment, Glaucoma, Vitrectomy, and Iridectomy.

Aliaa Abdelhakim, MD, PhD is Assistant Professor in Ophthalmology at Columbia University Irving Medical Center and Assistant Attending in NewYork Presbyterian Hospital.Dr. Abdelhakim is a board-certified ophthalmologist and retina specialist at the Harkness Eye Institute. She also completed her fellowship in Medical Genetics and Genomics at the Morgan Stanley Children's Hospital of New York. Dr. Abdelhakim specializes in conditions of the retina, as well as patients with genetic conditions affecting the eyes. Dr. Abdelhakim completed her medical school training at Columbia University Vagelos College of Physicians and Surgeons, followed by an ophthalmology residency and vitreoretinal surgical fellowship at the Columbia University Harkness Eye Institute, the latter under the mentorship of Tongalp Tezel, MD. Prior to her medical training, she completed a Ph.D. in biochemistry and molecular biology at the Massachusetts Institute of Technology, and a postdoctoral fellowship in Structural and Cell Biology at Harvard Medical School/ Children’s Hospital Boston. Dr. Abdelhakim has won numerous awards as a clinician and researcher, including Alpha Omega Alpha and the Heed Ophthalmic Fellowship. She was recently named the inaugural Burch-Chang Scholar, recognizing her as one of the rising research talents in ophthalmology. Dr. Abdelhakim is rated as an Experienced provider by MediFind in the treatment of Cone-Rod Dystrophy. Her top areas of expertise are Retinitis Pigmentosa, X-Linked Retinitis Pigmentosa (XLRP), Sorsby Fundus Dystrophy, and Leber Congenital Amaurosis.

Yu Hyon Kim, MD, is an attending physician, Retina and Assistant Professor, Ophthalmology & Visual Sciences at Montefiore Einstein. His clinical focus is in all aspects of vitreoretinal diseases evaluation, treatment and surgery, with a special interest in retinovascular disease, diabetes, macular degeneration, sickle cell and vascular occlusions. Dr. Kim is rated as an Experienced provider by MediFind in the treatment of Cone-Rod Dystrophy. His top areas of expertise are Diabetic Retinopathy, Retinal Artery Occlusion, Retinal Detachment, and Retinal Vein Occlusion.

Umar Mian is an Ophthalmologist in Bronx, New York. Dr. Mian is rated as an Experienced provider by MediFind in the treatment of Cone-Rod Dystrophy. His top areas of expertise are Diabetic Retinopathy, Retinopathy of Prematurity, Kallikrein Hypertension, Retinal Artery Occlusion, and Vitrectomy.

Nancy Coles is an Ophthalmologist in New York, New York. Dr. Coles is rated as an Experienced provider by MediFind in the treatment of Cone-Rod Dystrophy. Her top areas of expertise are Dry Eye Syndrome, Cataract, Glaucoma, and Choroid Plexus Carcinoma.

Susan Fromer is an Ophthalmologist in New York, New York. Dr. Fromer is rated as an Experienced provider by MediFind in the treatment of Cone-Rod Dystrophy. Her top areas of expertise are Glaucoma, Kallikrein Hypertension, Allergic Conjunctivitis, and Meibomianitis.

Talia Kaden is a General Surgeon and an Ophthalmologist in New York, New York. Dr. Kaden is rated as an Experienced provider by MediFind in the treatment of Cone-Rod Dystrophy. Her top areas of expertise are Retinal Detachment, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Vitrectomy, and Iridectomy.

David C. Ritterband MD, FACS is a Professor of Ophthalmology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Prior to joining Manhattan Eye, Ear and Throat Hospital (MEETH)/Northwell Eye Institute, he was a Professor of Ophthalmology at the Icahn School of Medicine at Mt Sinai and System Director of the Refractive Surgery Service for the Mount Sinai Health System. At MEETH he has assumed leadership of the Refractive Surgery division and the Laser Vision Correction Center and sees patients at the Manhattan Eye, Ear and Throat Hospital on 64th Street. Dr. Ritterband is a graduate of Duke University and received his medical degree at New York Medical College where he was elected to Alpha Omega Alpha, the national medical honor society. He completed his Ophthalmology Residency at New York Medical College where he was elected Chief Resident. He completed his Corneal and External disease and Refractive Surgery Fellowship at the University of Pittsburgh School of Medicine Eye and Ear Institute. He is a fellow of the American Academy of Ophthalmology and the American College of Surgeons. He is a past president of the Ocular Microbiology and Immunology Group and a long time Medical Board member of the Eye Bank for Sight Restoration in New York City, the world's first Eye Bank. In addition to maintaining a busy tertiary-care referral practice in New York City, Dr. Ritterband is a nationally recognized physician, scientist, and surgeon. He has published over 250 medical and scientific papers, book chapters, monographs, and research abstracts. He has lectured widely in the United States on cornea, cataract, and refractive surgery topics. His clinical and research interests include cornea transplantation, cataract surgery, ocular drug development, laser refractive surgery, and ocular infections. A committed teacher and mentor, he has trained over 50 clinical cornea fellows first at the highly regarded AUPO certified corneal fellowship program at the New York Eye and Ear Infirmary and continuing with the current AUPO corneal fellowship program at Manhattan Eye, Ear and Throat Hospital. Dr. Ritterband has received numerous awards including an Honor Award from the American Academy of Ophthalmology and has been named multiple times to New York Magazine's Best Doctors, Castle Connolly's Top Doctors, and the NY Times Magazine's Super Doctors. In addition, while at the New York Eye and Ear Infirmary he received 6 Resident Outstanding Teaching and Dedicated Service Awards. Dr. Ritterband is rated as an Experienced provider by MediFind in the treatment of Cone-Rod Dystrophy. His top areas of expertise are Cataract, Endophthalmitis, Interstitial Keratitis, Corneal Transplant, and Trabeculectomy.

Dr. Barile is Professor of Ophthalmology, Zucker School of Medicine at Hofstra /Northwell, and Director of Ophthalmology Research, Manhattan Eye, Ear and Throat Hospital. He previously served as the John Wilson Espy MD Professor of Clinical Ophthalmology and Glaubinger Scholar in Retina Research at Columbia University. Dr. Barile has lectured widely, has authored or coauthored more than eighty publications, and is a member of numerous professional societies and organizations including the Macula and Retina Societies. Among several honors, Dr. Barile received an Achievement Award from the American Academy of Ophthalmology and a Senior Honor Award from the American Society of Retina Specialists. Dr. Barile is rated as an Experienced provider by MediFind in the treatment of Cone-Rod Dystrophy. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Retinal Detachment, Retinal Vein Occlusion, and Vitrectomy.